Faidra Laskou Selected Research

eltrombopag

1/2017

Thrombopoetin receptor agonist therapy in thrombocytopenia: ITP and beyond.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Faidra Laskou Research Topics

Disease

1	Sarcopenia 12/2022
1	Frailty 12/2022
1	Osteoarthritis 12/2022
1	Osteoporosis 12/2022
1	Arthritis (Polyarthritis) 01/2017
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2017
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2017
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2017
1	Giant Cell Arteritis (Horton Disease) 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Systemic Juvenile Rheumatoid Arthritis 01/2017
1	Vasculitis (Vasculitides) 01/2017

Drug/Important Bio-Agent (IBA)

1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Inosine Triphosphate (ITP)IBA 01/2017
1	tocilizumab (atlizumab)FDA Link 01/2017
1	eltrombopag FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2017

Therapy/Procedure

1	Patient Care 12/2022
1	Therapeutics 01/2017